Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MXCT
DateTimeSourceHeadlineSymbolCompany
09/20/202411:02AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
09/16/20244:33AMAlliance NewsAlliance NewsMaxCyte touts strategic platform license deal with Kamau TherapeuticsLSE:MXCTMaxcyte Inc
09/16/20241:00AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
09/16/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
09/06/202411:07AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
09/06/20245:33AMRNS Non-RegulatoryMaxCyte, Inc. Bioprocessing Conference ParticipationLSE:MXCTMaxcyte Inc
09/03/20249:38AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
08/29/20244:06AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
08/07/20248:10AMAlliance NewsAlliance NewsMaxCyte reaffirms guidance as revenue jumps 24% in first halfLSE:MXCTMaxcyte Inc
08/07/20241:05AMRNS Regulatory NewsMaxCyte, Inc. Filing of Form 10-QLSE:MXCTMaxcyte Inc
08/07/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Second Quarter and Half-Year ResultsLSE:MXCTMaxcyte Inc
08/01/202410:31AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
07/31/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
07/10/20243:15AMRNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
07/09/20243:14AMRNS Regulatory NewsMaxCyte, Inc. Change of Name of Nominated Adviser and BrokerLSE:MXCTMaxcyte Inc
07/03/20241:00AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
07/02/20245:18AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
07/02/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
06/27/20248:34AMRNS Regulatory NewsMaxCyte, Inc. Publication of Annual ReportLSE:MXCTMaxcyte Inc
06/14/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Grant of Options and Restricted Stock UnitsLSE:MXCTMaxcyte Inc
06/12/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Result of AGMLSE:MXCTMaxcyte Inc
06/11/20245:10AMAlliance NewsAlliance NewsIN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 sharesLSE:MXCTMaxcyte Inc
06/11/20241:00AMRNS Regulatory NewsMaxCyte, Inc. PDMR DealingLSE:MXCTMaxcyte Inc
06/03/20249:22AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
05/29/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Participation in Upcoming Investor ConferenceLSE:MXCTMaxcyte Inc
05/22/20243:51PMAlliance NewsAlliance NewsIN BRIEF: MaxCyte inks deal with Legend Biotech for tech supplyLSE:MXCTMaxcyte Inc
05/22/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
05/20/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
05/14/20248:55AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
05/08/20243:46AMAlliance NewsAlliance NewsMaxCyte shares rise amid double-digit revenue increaseLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT